Apr 17, 2002
Guidant Sponsors Fellows Course to Educate Future Interventional Cardiologists

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, is pleased to announce that it is continuing its commitment as the primary sponsor of the 8th Annual Interventional Cardiology Fellows Course. The Fellows Course, a medical symposium of which Guidant is a founding sponsor, hosts hundreds of future physicians in San Jose, Calif., from Wednesday, April 17, through Sunday, April 20.

"The Fellows Course gives future interventional cardiologists insight into the latest practices in their chosen field," said John M. Capek, president, Vascular Intervention, Guidant Corporation. "Guidant is pleased to be a part of this forum for educating the physicians of tomorrow, who will go on to treat many of the more than 1.5 million patients each year who require an interventional procedure for cardiovascular and peripheral vascular disease."

The symposium features a faculty of some of the world's foremost experts in interventional cardiology who present various approaches to the treatment of coronary and peripheral vascular disease. Other topics include the future of interventional cardiology and the role of emerging therapies. Guidant-sponsored industry workshops cover the topics of Drug Eluting Stents, Intravascular Radiotherapy and Coronary Stenting.

"The Interventional Cardiology Fellows Course has become an established forum for innovators in the field to exchange knowledge and ideas," said Gregg W. Stone, M.D., FACC, of Lenox Hill Heart and Vascular Institute in New York, N.Y., and course director of the Interventional Cardiology Fellows Course. "Guidant's support has been instrumental in making this program an annual event and elevating this course to international stature."

"At this time of rapid technological innovation, the Fellows Course is more relevant than ever, both for the faculty and for the future interventional cardiologists," added Thomas J. Linnemeier, M.D., FACC, chief medical officer for Guidant Vascular Intervention, who serves as co-director of the Interventional Cardiology Fellows Course.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less- invasive care for some of life's most threatening medical conditions.